Abstract

In a pivotal study on polycystic ovary syndrome, 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] was found to significantly mitigate palmitic acid-induced apoptosis in ovarian granulosa cells, which is crucial for oocyte development. The study used a high-fat cell model with palmitic acid to simulate the elevated free fatty acids found in obese polycystic ovary syndrome patients. Findings revealed that pretreatment with 1,25-(OH)2D3 reversed the detrimental effects of palmitic acid, including decreased cell viability and increased apoptosis, by modulating the inositol-requiring transmembrane kinase endoribonuclease-1α/ X-box-binding protein 1 spliced pathway. These results suggest a promising role for vitamin D in treating polycystic ovary syndrome and offer a new theoretical basis for its application in reproductive health.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call